Mass Spec Focus NovaBioAssays specializes in advanced mass spectrometry solutions for drug discovery and development, presenting a strong upsell opportunity to CRO clients seeking quantitative and qualitative analysis of proteins and small molecules.

ADC and Glycoproteins Services in antibody-drug conjugates and glycoprotein characterization offer a differentiator for biotech and pharma teams advancing complex biologics, suggesting targeted outreach to ADC developers and biosimilar programs.

Epitope Mapping Hydrogen deuterium exchange MS for epitope mapping positions NovaBioAssays as a partner for biosimilar development and epitope-focused projects, presenting a potential entry point with biologics manufacturers and CROs expanding biosimilar portfolios.

Mid-market Revenue With revenue in the mid-range and a Boston-area footprint, there is an opportunity to target mid-sized pharma/biotech firms in need of specialized MS services without engaging a large CRO, offering flexible collaboration models.

Tech Stack Synergies Utilize existing technology partnerships and platforms (SCIEX, ASP.NET, MySQL, Microsoft 365) to streamline collaborative projects, suggesting joint marketing or co-sell programs with compatible vendors to accelerate service delivery.